Keyphrases
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Screening Study
100%
Screening Failures
100%
Study Withdrawal
100%
Clinical Trials
50%
Baseline Factors
50%
Multivariable Model
33%
Peru
16%
C(T)
16%
Hazard Ratio
16%
Phase II Trial
16%
Baseline Predictors
16%
Cape Town
16%
South Africa
16%
Cox Proportional Hazards Regression
16%
Levofloxacin
16%
Non-adherence
16%
Lima
16%
Prevalence Ratio
16%
Susceptibility Testing
16%
Resistance Profile
16%
Sputum
16%
Poisson Regression
16%
Withdrawal of Consent
16%
Culture Conversion
16%
Nonconsent
16%
Optimized Background Regimen
16%
Medicine and Dentistry
Multidrug Resistant Tuberculosis
100%
Clinical Trial
75%
Prevalence
25%
Hazard Ratio
25%
Proportional Hazards Model
25%
Levofloxacin
25%
Culture Conversion
25%
Sputum
25%
Phase II Trials
25%
Pharmacology, Toxicology and Pharmaceutical Science
Multi-Drug-Resistant Tuberculosis
100%
Clinical Trial
75%
Prevalence
25%
Phase II Trials
25%
Levofloxacin
25%